A carregar...
Editorial focus: understanding off-target effects as the key to successful RNAi therapy
With the first RNA interference (RNAi) drug (ONPATTRO (patisiran)) on the market, we witness the RNAi therapy field reaching a critical turning point, when further improvements in drug candidate design and delivery pipelines should enable fast delivery of novel life changing treatments to patients....
Na minha lista:
| Publicado no: | Cell Mol Biol Lett |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902517/ https://ncbi.nlm.nih.gov/pubmed/31867046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11658-019-0196-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|